文献速递贫血与红细胞疾病

铁蛋白在预测血液病患者骨髓铁储备方面优于其他生物标志物

Ferritin outperforms other biomarkers in predicting bone marrow iron stores in patients with hematologic disorders.
PubMed 文献 · Blood Adv · 2025-01-01

该回顾性研究纳入6610例血液病患者,比较铁蛋白、转铁蛋白饱和度、可溶性转铁蛋白受体等指标与骨髓铁染色的符合度。铁蛋白预测骨髓铁减少的AUC女性88%、男性89%,均高于其他指标;铁蛋白30 μg/L截断点特异性女性97%、男性99%,但敏感性仅54%和35%。多变量模型未优于单用铁蛋白。

要点

  • 铁蛋白预测骨髓铁减少的AUC女性88%(95%CI 86-90),男性89%(95%CI 87-91),优于其他生物标志物。
  • 铁蛋白30 μg/L截断点特异性女性97%、男性99%,敏感性仅54%和35%。
  • 多变量逻辑回归模型预测性能未显著优于单用铁蛋白。

核心结论

  • 在大型二级医疗人群中,铁蛋白是预测铁缺乏的最佳单一生物标志物。
  • 在血液病患者中,即使铁蛋白水平很高,也不能以95%的把握排除铁缺乏。

研究设计与样本

  • 回顾性研究,从赫尔辛基大学医院电子健康记录中收集6610例患者(中位年龄66岁)的铁染色结果及同期铁蛋白、转铁蛋白饱和度、可溶性转铁蛋白受体、转铁蛋白、血红蛋白和平均红细胞体积结果。

主要发现

  • 受试者工作特征分析中,铁蛋白预测骨髓铁减少的AUC女性88%(95%CI 86-90),男性89%(95%CI 87-91),其他生物标志物AUC较低。
  • 铁蛋白30 μg/L截断点特异性女性97%、男性99%,敏感性女性54%、男性35%。
  • 多变量逻辑回归模型预测性能未显著优于单用铁蛋白。
  • 预概率50%时,铁蛋白30 μg/L(女性)和51 μg/L(男性)对铁储备减少的阳性预测值为95%。
  • 预概率50%时,阴性预测值95%对应的铁蛋白水平为女性1750 μg/L、男性4967 μg/L。

关键数值与推荐

  • 铁蛋白预测骨髓铁减少的AUC:女性88%(95%CI 86-90),男性89%(95%CI 87-91)。
  • 铁蛋白30 μg/L截断点:特异性女性97%、男性99%,敏感性女性54%、男性35%。
  • 预概率50%时,铁蛋白30 μg/L(女性)和51 μg/L(男性)的阳性预测值为95%。
  • 预概率50%时,阴性预测值95%对应的铁蛋白水平为女性1750 μg/L、男性4967 μg/L。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although iron-deficiency anemia is common, interpreting iron laboratory test results can be challenging in patients with comorbidities. We aimed to study the accuracy of common iron biomarkers compared with bone marrow iron staining in a large retrospective data set of patients with hematologic disorders. We collected from 6610 patients (median age, 66 years) results of iron staining, with their concurrent ferritin, transferrin saturation, soluble transferrin receptor, transferrin, hemoglobin, and mean red blood cell volume results from Helsinki University Hospital electronic health records. In receiver operating characteristics analysis, ferritin had the highest area under the curve (AUC) with 88% (95% confidence interval [CI], 86-90) for females and 89% (95% CI, 87-91) for males in predicting reduced bone marrow iron. Using a ferritin cutoff of 30 μg/L resulted in high specificity rates of 97% in females and 99% in males. However, sensitivity rates were only 54% and 35%, respectively. Other studied biomarkers had inferior AUCs. Multivariate logistic regression models did not significantly perform better in prediction than ferritin alone. With 50% preprobability for reduced iron stores, a ferritin of 30 μg/L (females) and 51 μg/L (males) had a 95% positive predictive value for reduced iron stores. A 95% negative predictive value was achieved at 1750 μg/L (females) and 4967 μg/L (males). In our large population study, ferritin was the best single biomarker for iron deficiency in secondary care. Adding other blood tests in a multivariate model did not improve performance. However, in these patients with hematologic disorders, even a high ferritin did not rule out iron deficiency with 95% certainty.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lahtiharju T, Savola P, Lempiäinen A, et al. Ferritin outperforms other biomarkers in predicting bone marrow iron stores in patients with hematologic disorders. Blood Adv. 2025. PMID: 39841943. doi:10.1182/bloodadvances.2024014283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。